AdvisorShares Trust has filed a new summary prospectus for its AdvisorShares Pure US Cannabis ETF, effective November 1, 2026. This filing is crucial as it outlines the fund's investment objectives, fees, and risks associated with investing in cannabis-related companies. The update reflects ongoing adjustments in the cannabis investment landscape, which is particularly important given the complex regulatory environment surrounding cannabis.

The AdvisorShares Pure US Cannabis ETF, trading under the ticker MSOS, aims for long-term capital appreciation by investing in companies that derive a significant portion of their revenue from the cannabis industry. The filing indicates a commitment to transparency and regulatory compliance, which is essential in the evolving cannabis industry. This move may also influence competitors in the ETF space, prompting them to adapt their offerings in response to these changes.

Background

AdvisorShares Trust is an investment company incorporated in Delaware. The company focuses on actively managed exchange-traded funds (ETFs), with a specific emphasis on niche markets. The current filing is part of a series of recent submissions, all dated October 30, 2026, which includes multiple 497K forms. The AdvisorShares Pure US Cannabis ETF is designed to provide investors with exposure to the cannabis sector, which has been growing due to increasing legalization and acceptance.

What the Filing Says

The recent filing outlines the investment objective of the AdvisorShares Pure US Cannabis ETF, stating that it seeks long-term capital appreciation. It details the fund's fee structure, including management fees of 0.60% and total annual operating expenses of 0.75%. The filing emphasizes that the fund will invest at least 80% of its net assets in securities of companies that derive at least 50% of their revenue from the marijuana and hemp business in the United States.

Impact

This update may affect investors looking for exposure to the cannabis sector, as it clarifies the fund's investment strategies and associated risks. The cannabis industry remains highly regulated, and the fund's compliance with these regulations is critical for its success. Additionally, the filing indicates that AdvisorShares Trust is positioning itself as a transparent player in the cannabis ETF market, which could influence investor confidence and interest.

What's Next

Following this filing, it is expected that AdvisorShares Trust will continue to monitor regulatory changes and market conditions affecting the cannabis industry. The filing does not specify any immediate next steps, but ongoing updates and adjustments to the fund's offerings may be anticipated as the cannabis landscape evolves.